Clinical Trials

Clinical Trials Update: July 23, 2008 (HealthDay via Yahoo! News)

23 Jul 2008

(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:

MethylGene stops enrolling patients in Hodgkin's drug trials (C-Health)

23 Jul 2008

Cancer drug developer MethylGene Inc. (TSX:MYG) said Tuesday that it has temporarily halted the enrolment of new patients into clinical trials of its treatment for Hodgkin's lymphoma.

CeNeRx BioPharma Finalizes Plans To Initiate Phase II Trials For Its Novel Antidepressant Agent Tyrima(TM) Using ... (Medical News Today)

23 Jul 2008

CeNeRx BioPharma, Inc., a clinical stage company developing and commercializing innovative treatments for diseases of the central nervous system, announced plans to advance its lead candidate Tyrima(TM) into Phase II trials for the treatment of depression and anxiety.